Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-04-11
2006-04-11
Richter, Johann (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S491000
Reexamination Certificate
active
07026348
ABSTRACT:
A class of novel acylsulfonamide substituted indole compounds is disclosed together with the use of such compounds for inhibiting sPLA2mediated release of fatty acids for treatment of inflammatory diseases such as septic shock.
REFERENCES:
patent: 5578634 (1996-11-01), Bach et al.
patent: 5641800 (1997-06-01), Bach et al.
patent: 5654326 (1997-08-01), Bach et al.
patent: 5684034 (1997-11-01), Bach et al.
patent: 6451839 (2002-09-01), Bach et al.
patent: 6608099 (2003-08-01), Mihelich et al.
Mihelich Edward David
Phillips Michael LeRoy
Warshawsky Alan M
Benjamin Roger S.
Eli Lilly and Company
Ginah Francis O.
Richter Johann
Sackey Ebenezer
LandOfFree
Indole sPLA2 inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Indole sPLA2 inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Indole sPLA2 inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3588249